BILL ANALYSIS                                                                                                                                                                                                    �



                                                                  SB 1410
                                                                  Page  1

          Date of Hearing:   August 8, 2012

                        ASSEMBLY COMMITTEE ON APPROPRIATIONS
                                Felipe Fuentes, Chair

                   SB 1410 (Hernandez) - As Amended:  May 25, 2012 

          Policy Committee:                             HealthVote:19-0

          Urgency:     No                   State Mandated Local Program: 
          No     Reimbursable:              

           SUMMARY  

          This bill would make several changes to the Independent Medical 
          Review (IMR) process for health care consumers seeking to appeal 
          a decision made by their health plan or insurer. Specifically, 
          this bill: 

          1)Increases the level of expertise required of the individuals 
            reviewing the appeal, by requiring them to be expert in the 
            treatment of the consumer's specific medical condition.

          2)Requires applications for an appeal to include a section where 
            consumers could voluntarily disclose demographic data.

          3)Requires decisions made by reviewers on appeal to be available 
            to the public, and eliminates the current prohibition on 
            including the name of the health plan or insurer in public 
            documents.

          4)Requires the Department of Insurance (CDI) and Department of 
            Managed Health Care (DMHC) establish a database, searchable by 
            the public, listing all decisions made on IMR appeals, as well 
            as a lengthy list of facts and data about each decision, as 
            specified.

           FISCAL EFFECT  

          1)One-time costs of about $125,000 for DMHC to revise its 
            existing database (Managed Care Fund).

          2)Ongoing costs of about $100,000 per year for DMHC to input and 
            manage additional data, and $200,000 per year for DMHC to 
            provide medical consultants with increased clinical expertise 








                                                                  SB 1410
                                                                  Page  2

            (Managed Care Fund). 

          3)One-time costs of about $580,000 for CDI to revise its 
            existing database (Insurance Fund).  CDI's system is a legacy 
            system and more costly to upgrade.

          4)Ongoing costs of about $100,000 per year for CDI to input and 
            manage additional data, and $200,000 per year for CDI to 
            provide medical consultants with increased clinical expertise 
            (Insurance Fund).

            Both DMHC and CDI have estimated the cost of developing a IMR 
            database. Because the database will be shared between the 
            departments, there may be some economies of scale and the 
            final costs may be lower than the combined costs of both 
            departments' estimates.

           COMMENTS  

           1)Background and Purpose.  Under current law, health care 
            consumers who have been denied coverage of services can appeal 
            to the state's independent medical review process. There are 
            three categories of decisions that can be appealed through 
            this process: coverage decisions related to medical necessity 
            of a service, the urgency of medical care, and the need for 
            experimental or investigational services. Under independent 
            medical review, an outside contractor arranges for medical 
            professionals with relevant training and experience to review 
            the consumer's appeal and decide whether to overturn the 
            coverage decision.

            The California HealthCare Foundation (CHCF) evaluated 10 years 
            of IMR cases in California and identified a number of areas in 
            which the IMR process could be improved. The study revealed 
            inconsistent resolutions for similar IMR cases, a lack of 
            clarity and transparency regarding the basis for decisions 
            made by IMR reviewers, and evidence that the qualifications 
            and training of IMR reviewers may be poorly matched to the 
            cases they review.  Additionally, the report suggested making 
            IMR resolutions public, requiring that a greater level of 
            detail and scientific data accompany case resolutions, and 
            allowing demographic data to be collected on consumers using 
            the IMR system. This bill attempts to remedy some of the 
            weaknesses found by the CHCF study.









                                                                  SB 1410
                                                                  Page  3

            The bill requires the IMR database to show the annual number, 
            rate, and resolution ratios of IMR cases by health plan or 
            insurer, as well as similar information for different 
            demographics in the customer base. The end result is intended 
            to be greater insight into the behavior and decision-making of 
            companies in the health care industry, and into variance in 
            IMR outcomes by race.

           2)Support. This bill is supported by a broad coalition of 
            medical groups, consumers groups, and health access groups. 
            There is no known opposition.

           3)Support If Amended.  The California Association of Health Plans 
            (CAHP) would support this bill if it is amended to exclude the 
            name of the health plan associated with specific IMR cases.  
            CAHP believes including the plan name without any meaningful 
            context can be misleading to consumers. Kaiser Permanente also 
            supports an amendment to exclude from publication the name of 
            the health plan associated with specific IMR cases. Failing 
            that, Kaiser Permanente supports amendments that (1) implement 
            another CHCF recommendation that would require a more thorough 
            review of the IMR organizations, (2) require all 
            communications and inquiries be transmitted to each party 
            involved in the IMR process and posted on the web site, and 
            (3) require a consumer disclosure notice that provides more 
            context about the IMR process.  The last amendment appears to 
            be intended to protect the reputation of health plans and 
            insurers. Kaiser Permanente's proposed amendments would drive 
            up the cost of the bill substantially. 

           Analysis Prepared by  :    Jonathan Stein / APPR. / (916) 319-2081